. 2008 Oct 13;14(1-2):381–391. doi: 10.1111/j.1582-4934.2008.00548.x

Table 1.

Immuohistochemical analysis of human prostate cancer PC-3 s.c. xenogrft tumours

Treatment group	Ki-67^a	TUNEL^a	CD31^a
Ad-LacZ	596 ± 144	6 ± 2	52 ± 15
Ad-LacZ +Doc	512 ± 113	25 ± 6 ^b	42 ± 11
E10A	370 ± 100 ^b	28 ± 9 ^b	21 ± 4 ^b
E10A+Doc	228 ± 78 ^c	67 ± 18 ^d	10 ± 3 ^d

Median number proliferating cells (Ki-67 stain), apoptotic cells (TUNEL stain) and vessels (CD31 stain), respectively, per high-power field (×200).

P < 0.05, compared with Ad-LacZ control.

P < 0.05, compared with E10A and docetaxel plus Ad-LacZ.